21.02.2013 Views

marks published for opposition - U.S. Patent and Trademark Office

marks published for opposition - U.S. Patent and Trademark Office

marks published for opposition - U.S. Patent and Trademark Office

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

JULY 17, 2012 U.S. PATENT AND TRADEMARK OFFICE TM 483<br />

CLASS 5—(Continued).<br />

SN 85-500,405. BIO-ZOO, S.A. DE C.V., ZAPOPAN, JALISCO,<br />

MEXICO, FILED 12-20-2011.<br />

PRIORITY CLAIMED UNDER SEC. 44(D) ON MEXICO<br />

APPLICATION NO. 1191173, FILED 7-1-2011, REG. NO.<br />

1253255, DATED 11-22-2011, EXPIRES 7-1-2021.<br />

THE MARK CONSISTS OF A BLACK TRIANGLE LIKE<br />

GEOMETRIC FIGURE OUTLINED WITH A WHITE AND<br />

BLACK LINE, WITH THE WORDING "BIO ZOO" WRITTEN<br />

IN WHITE WITH A BLACK OUTLINE AND ABOVE THIS<br />

AN ABSTRACT DESIGN CONSISTING OF A STRAIGHT<br />

LINE WITH CURVED LINES ON EACH SIDE.<br />

FOR PHARMACEUTICAL PREPARATIONS FOR ANI-<br />

MAL SKINCARE, PHARMACEUTICAL PREPARATIONS<br />

FOR THE PREVENTION AND TREATMENT OF OCU-<br />

LAR DISORDERS OR DISEASES, FOR THE TREAT-<br />

MENT OF BACTERIA-BASED DISEASES, AND FOR<br />

THE TREATMENT OF DIABETES, AND ANTI-INFEC-<br />

TIVE PREPARATIONS, ANTIVIRAL PREPARATIONS,<br />

ANTIBIOTICS, ANTIFUNGAL PREPARATIONS AND<br />

VACCINES, PHARMACEUTICAL PREPARATIONS AND<br />

SUBSTANCES FOR THE TREATMENT OF INFECTIOUS<br />

DISEASES, BLOOD DISORDERS, PAIN, INFLAMMA-<br />

TION, SEPSIS, ALOPECIA, OBESITY AND COGNITIVE<br />

DISORDERS, PHARMACEUTICAL PREPARATIONS<br />

AND SUBSTANCES FOR THE TREATMENT OF VIRAL,<br />

METABOLIC, ENDOCRINE, MUSCULOSKELETAL,<br />

CARDIOVASCULAR, CARDIOPULMONARY, GENI-<br />

TOURINARY, SEXUAL DYSFUNCTION, ONCOLOGI-<br />

CAL, HEPATOLOGICAL, OPHTHALMIC,<br />

RESPIRATORY, NEUROLOGICAL, GASTROINTEST-<br />

INAL, HORMONAL, DERMATOLOGICAL, PSYCHIA-<br />

TRIC AND IMMUNE SYSTEM RELATED DISEASES<br />

AND DISORDERS, PHARMACEUTICAL PREPARA-<br />

TIONS FOR THE TREATMENT OF WORMS IN PETS,<br />

PLANT EXTRACTS FOR MEDICAL, VETERINARY AND<br />

PHARMACEUTICAL PURPOSES, YEAST OR YEAST<br />

EXTRACTS FOR MEDICAL, VETERINARY OR PHAR-<br />

MACEUTICAL PURPOSES, ANTI-INFECTIVE PRO-<br />

DUCTS FOR VETERINARY USE, BACTERIAL AND<br />

BACTERIOLOGICAL PREPARATIONS FOR MEDICAL<br />

OR VETERINARY PURPOSES, DIAGNOSTIC PREPARA-<br />

TIONS FOR MEDICAL AND VETERINARY USE, DIAG-<br />

NOSTIC PREPARATIONS FOR MEDICAL OR<br />

VETERINARY PURPOSES, VETERINARY PREPARA-<br />

TIONS, NAMELY, PAIN RELIEF MEDICATION, VETER-<br />

INARY PREPARATIONS FOR TREATMENT OF<br />

INTESTINAL BACTERIA, VETERINARY PREPARA-<br />

TIONS, NAMELY, ANTIOXIDANTS, VETERINARY<br />

VACCINES, BACTERIOSTATS FOR MEDICINAL, DEN-<br />

TAL AND VETERINARY USE, DISINFECTANTS FOR<br />

HYGIENIC PURPOSES, PESTICIDES, RODENTICIDES<br />

(U.S. CLS. 6, 18, 44, 46, 51 AND 52).<br />

NORA BUCHANAN WILL, EXAMINING ATTORNEY<br />

CLASS 5—(Continued).<br />

SN 85-502,068. CHERRY CAPITAL SERVICES, INC., TRA-<br />

VERSE CITY, MI. FILED 12-22-2011.<br />

THE MARK CONSISTS OF STANDARD CHARACTERS<br />

WITHOUT CLAIM TO ANY PARTICULAR FONT, STYLE,<br />

SIZE, OR COLOR.<br />

FOR DIETARY SUPPLEMENTS MADE FROM CHER-<br />

RIES (U.S. CLS. 6, 18, 44, 46, 51 AND 52).<br />

FIRST USE 3-3-2003; IN COMMERCE 3-3-2003.<br />

ELISSA GARBER KON, EXAMINING ATTORNEY<br />

SN 85-506,442. BISHOP-LYONS ENTERTAINMENT LLC,<br />

DBA NATURALBODY, ENCINO, CA. FILED 12-30-2011.<br />

THE MARK CONSISTS OF A SILHOUETTE OF A BIG<br />

CAT RUNNING WITH HALF OF THE CAT BEING A<br />

SERRATED DESIGN.<br />

FOR NUTRITIONAL SUPPLEMENTS IN THE FORM<br />

OF MEAL REPLACEMENTS, NAMELY, PROTEIN BARS,<br />

PROTEIN DRINKS, FAT BURNERS IN THE NATURE<br />

OF DIETING PILLS AND POWDER PREPARATIONS TO<br />

PROMOTE FAT BURNING AND SPORTS NUTRITION<br />

PRODUCTS, NAMELY, ELECTROLYTES, BRANCH<br />

CAIN AMINO ACIDS (BCAAS), VITAMINS, MINERAL<br />

SUPPLEMENTS, HUMAN GROWTH HORMONE AND<br />

IFG-1 PRODUCTS, NAMELY, GROWTH HORMONE<br />

SUPPLEMENTS THAT INCREASE GROWTH LEVELS<br />

NATURALLY, CARTILAGE BUILDING BLOCKS,<br />

NAMELY, SUPPLEMENTS THAT SUPPORT JOINT<br />

STRENGTH AND FLEXIBILITY, ANTIOXIDANT SUP-<br />

PLEMENTS, ESSENTIAL FATTY ACIDS FOR USE AS A<br />

NUTRITIONAL SUPPLEMENT, NATURAL ANTI-IN-<br />

FLAMMATORY DIETARY ENZYMES, ANDROGENIC-<br />

ANABOLIC-TESTOSTERONE HORMONE SUPPLE-<br />

MENTS, HERBAL SUPPLEMENTS AND NATURAL<br />

SLEEP FORMULA PREPARATIONS (U.S. CLS. 6, 18, 44,<br />

46, 51 AND 52).<br />

FIRST USE 6-7-2011; IN COMMERCE 8-20-2011.<br />

DOMINIC FATHY, EXAMINING ATTORNEY

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!